Emily M Ingalls, John J Veillette, Jared Olson, Stephanie S May, C Dustin Waters, Stephanie S Gelman, George Vargyas, Mary Hutton, Nick Tinker, Gabriel V Fontaine, Rachel A Foster, Jena Stallsmith, Ali Earl, Whitney R Buckel, Todd J Vento
{"title":"多元干预对 23 家社区医院急诊科膀胱炎和无症状细菌尿抗生素处方的影响。","authors":"Emily M Ingalls, John J Veillette, Jared Olson, Stephanie S May, C Dustin Waters, Stephanie S Gelman, George Vargyas, Mary Hutton, Nick Tinker, Gabriel V Fontaine, Rachel A Foster, Jena Stallsmith, Ali Earl, Whitney R Buckel, Todd J Vento","doi":"10.1177/00185787231159578","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Urinary tract infections (UTIs) are over-diagnosed and over-treated in the emergency department (ED) leading to unnecessary antibiotic exposure and avoidable side effects. However, data describing effective large-scale antimicrobial stewardship program (ASP) interventions to improve UTI and asymptomatic bacteriuria (ASB) management in the ED are lacking. <b>Methods:</b> We implemented a multifaceted intervention across 23 community hospital EDs in Utah and Idaho consisting of in-person education for ED prescribers, updated electronic order sets, and implementation/dissemination of UTI guidelines for our healthcare system. We compared ED UTI antibiotic prescribing in 2021 (post-intervention) to baseline data from 2017 (pre-intervention). The primary outcomes were the percent of cystitis patients prescribed fluoroquinolones or prolonged antibiotic durations (>7 days). Secondary outcomes included the percent of patients treated for UTI who met ASB criteria, and 14-day UTI-related readmissions. <b>Results:</b> There was a significant decrease in prolonged treatment duration for cystitis (29% vs 12%, <i>P</i> < .01) and treatment of cystitis with a fluoroquinolone (32% vs 7%, <i>P</i> < .01). The percent of patients treated for UTI who met ASB criteria did not change following the intervention (28% pre-intervention versus 29% post-intervention, <i>P</i> <i>=</i> .97). A subgroup analysis indicated that ASB prescriptions were highly variable by facility (range 11%-53%) and provider (range 0%-71%) and were driven by a few high prescribers. <b>Conclusions:</b> The intervention was associated with improved antibiotic selection and duration for cystitis, but future interventions to improve urine testing and provide individualized prescriber feedback are likely needed to improve ASB prescribing practice.</p>","PeriodicalId":13002,"journal":{"name":"Hospital Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288455/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of a Multifaceted Intervention on Antibiotic Prescribing for Cystitis and Asymptomatic Bacteriuria in 23 Community Hospital Emergency Departments.\",\"authors\":\"Emily M Ingalls, John J Veillette, Jared Olson, Stephanie S May, C Dustin Waters, Stephanie S Gelman, George Vargyas, Mary Hutton, Nick Tinker, Gabriel V Fontaine, Rachel A Foster, Jena Stallsmith, Ali Earl, Whitney R Buckel, Todd J Vento\",\"doi\":\"10.1177/00185787231159578\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Urinary tract infections (UTIs) are over-diagnosed and over-treated in the emergency department (ED) leading to unnecessary antibiotic exposure and avoidable side effects. However, data describing effective large-scale antimicrobial stewardship program (ASP) interventions to improve UTI and asymptomatic bacteriuria (ASB) management in the ED are lacking. <b>Methods:</b> We implemented a multifaceted intervention across 23 community hospital EDs in Utah and Idaho consisting of in-person education for ED prescribers, updated electronic order sets, and implementation/dissemination of UTI guidelines for our healthcare system. We compared ED UTI antibiotic prescribing in 2021 (post-intervention) to baseline data from 2017 (pre-intervention). The primary outcomes were the percent of cystitis patients prescribed fluoroquinolones or prolonged antibiotic durations (>7 days). Secondary outcomes included the percent of patients treated for UTI who met ASB criteria, and 14-day UTI-related readmissions. <b>Results:</b> There was a significant decrease in prolonged treatment duration for cystitis (29% vs 12%, <i>P</i> < .01) and treatment of cystitis with a fluoroquinolone (32% vs 7%, <i>P</i> < .01). The percent of patients treated for UTI who met ASB criteria did not change following the intervention (28% pre-intervention versus 29% post-intervention, <i>P</i> <i>=</i> .97). A subgroup analysis indicated that ASB prescriptions were highly variable by facility (range 11%-53%) and provider (range 0%-71%) and were driven by a few high prescribers. <b>Conclusions:</b> The intervention was associated with improved antibiotic selection and duration for cystitis, but future interventions to improve urine testing and provide individualized prescriber feedback are likely needed to improve ASB prescribing practice.</p>\",\"PeriodicalId\":13002,\"journal\":{\"name\":\"Hospital Pharmacy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2023-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288455/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hospital Pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/00185787231159578\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/3/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/00185787231159578","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/3/5 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
摘要
背景:尿路感染(UTI)在急诊科(ED)中被过度诊断和治疗,导致不必要的抗生素暴露和可避免的副作用。然而,目前还缺乏有效的大规模抗菌药物管理计划(ASP)干预措施来改善急诊科对UTI和无症状菌尿(ASB)的管理。方法:我们在犹他州和爱达荷州的 23 家社区医院急诊室实施了一项多方面的干预措施,包括对急诊室处方人员进行面对面教育、更新电子医嘱集以及为我们的医疗保健系统实施/传播 UTI 指南。我们将 2021 年(干预后)的急诊室 UTI 抗生素处方与 2017 年(干预前)的基线数据进行了比较。主要结果是处方氟喹诺酮类药物或延长抗生素使用时间(>7 天)的膀胱炎患者比例。次要结果包括符合 ASB 标准的UTI 患者比例,以及 14 天UTI 相关再住院率。结果膀胱炎治疗时间延长的比例明显下降(29% 对 12%,P P = .97)。亚组分析表明,ASB 处方在不同医疗机构(范围为 11%-53%)和医疗服务提供者(范围为 0%-71%)之间存在很大差异,且主要由少数高处方率的医生开具。结论干预措施与膀胱炎抗生素选择和疗程的改善有关,但未来可能需要改进尿液检测和提供个性化处方反馈的干预措施,以改善ASB处方实践。
Impact of a Multifaceted Intervention on Antibiotic Prescribing for Cystitis and Asymptomatic Bacteriuria in 23 Community Hospital Emergency Departments.
Background: Urinary tract infections (UTIs) are over-diagnosed and over-treated in the emergency department (ED) leading to unnecessary antibiotic exposure and avoidable side effects. However, data describing effective large-scale antimicrobial stewardship program (ASP) interventions to improve UTI and asymptomatic bacteriuria (ASB) management in the ED are lacking. Methods: We implemented a multifaceted intervention across 23 community hospital EDs in Utah and Idaho consisting of in-person education for ED prescribers, updated electronic order sets, and implementation/dissemination of UTI guidelines for our healthcare system. We compared ED UTI antibiotic prescribing in 2021 (post-intervention) to baseline data from 2017 (pre-intervention). The primary outcomes were the percent of cystitis patients prescribed fluoroquinolones or prolonged antibiotic durations (>7 days). Secondary outcomes included the percent of patients treated for UTI who met ASB criteria, and 14-day UTI-related readmissions. Results: There was a significant decrease in prolonged treatment duration for cystitis (29% vs 12%, P < .01) and treatment of cystitis with a fluoroquinolone (32% vs 7%, P < .01). The percent of patients treated for UTI who met ASB criteria did not change following the intervention (28% pre-intervention versus 29% post-intervention, P= .97). A subgroup analysis indicated that ASB prescriptions were highly variable by facility (range 11%-53%) and provider (range 0%-71%) and were driven by a few high prescribers. Conclusions: The intervention was associated with improved antibiotic selection and duration for cystitis, but future interventions to improve urine testing and provide individualized prescriber feedback are likely needed to improve ASB prescribing practice.
期刊介绍:
Hospital Pharmacy is a monthly peer-reviewed journal that is read by pharmacists and other providers practicing in the inpatient and outpatient setting within hospitals, long-term care facilities, home care, and other health-system settings The Hospital Pharmacy Assistant Editor, Michael R. Cohen, RPh, MS, DSc, FASHP, is author of a Medication Error Report Analysis and founder of The Institute for Safe Medication Practices (ISMP), a nonprofit organization that provides education about adverse drug events and their prevention.